Current recommendations surrounding the administration of the second COVID-19 vaccine dose to patients who experience an immediate hypersensitivity reaction to the first dose are conflicting.
Study authors evaluated whether using an observational study that includes Medicare claims data could detect the proarrhythmic risk of medications known to prolong the QT interval.
This meta-analysis aimed to determine the association between SGLT2i use and arrhythmias in patients with T2DM or HF.
The authors reported that 25 of the total 233 patients included in the study experienced a bleeding event.
The extension study included a total of 84 adult FD patients who completed the FACETS, ATTRACT, or AT1001-041 study.
To identify medications with potential proarrhythmic association.
To evaluate the association, the study authors utilized healthcare databases from Ontario, Canada to identify adults 66 years of age and older with no history of AF who filled at least 1 prescription for levothyroxine.
The aim of the study was to analyze antihypertensive utilization patterns among patients with uncontrolled hypertension despite receiving therapy.
The objective of the statement was to review and discuss medications that may cause or exacerbate arrhythmias.
The aim of the study was to use real-world data to compare the risk of cardiac events in new users of azithromycin vs amoxicillin.
